AC
NUVB icon

AXQ Capital’s Nuvation Bio NUVB Stock Holding History

AXQ Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-84,710
Closed -$363K – 1240
2026
Q1 		$363K Buy
84,710
+73,061
+627% +$407K 0.05% 526
2025
Q4 		$104K Sell
11,649
-105,961
-90% -$656K 0.02% 647
2025
Q3 		$435K Buy
117,610
+22,215
+23% +$60.5K 0.17% 224
2025
Q2 		$186K Buy
+95,395
New +$199K 0.06% 471

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

AXQ Capital's NUVB Position: Q2 2026 in Review

AXQ Capital sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 84,710 shares — an estimated $363K sold.

AXQ Capital first reported a position in NUVB in Q2 2025 and held it in 4 quarters. The position peaked at $435K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • AXQ Capital reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 84,710 Nuvation Bio shares in Q2 2026, an estimated $363K.
  • AXQ Capital first reported a position in Nuvation Bio in Q2 2025 and held it in 4 quarters.
  • AXQ Capital's Nuvation Bio position peaked at $435K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.